Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition RiskZoe Moodie, M. Juliana McElrath, Yunda Huang et al.|The Journal of Infectious Diseases|2022Cited by 50
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIVNonhlanhla N. Mkhize, Sinead Delany‐Moretlwe, Bo Zhang et al.|Nature Communications|2025Cited by 1